You are here

Study Evaluating GSI-953 in Healthy Young and Alzheimer's Patients

Last updated on March 11, 2019

FOR MORE INFORMATION
Study Location
Glendale, California, 91206 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Alzheimer Disease
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- For Healthy Young Subjects: Healthy as determined by the investigator on the basis of
medical history, physical examination, clinical laboratory test results, vital signs
and 12 lead ECGs.

- For AD patients: Patients must be generally healthy with the exception of Alzheimer
Disease. (same as above)

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- For Healthy Young Subjects: Healthy as determined by the investigator on the basis of
medical history, physical examination, clinical laboratory test results, vital signs
and 12 lead ECGs.

- For AD patients: Patients must be generally healthy with the exception of Alzheimer
Disease. (same as above)

NCT00479219
Pfizer
Completed
Study Evaluating GSI-953 in Healthy Young and Alzheimer's Patients

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now